Search

everythinglearnresearchcommunity

for

Search:↓

Quality pharmaceutical care is crucial for safe and effective use of vitamin-mineral supplements during pregnancy and breastfeeding.

People with skin diseases feel more stigmatized than those without.

Emotional symptoms from alopecia areata reduce work productivity and daily activity.

Finasteride helps reduce prostate size and symptoms in BPH but is less effective than terazosin and works best for larger prostates.

WNMFDDA effectively predicts drug-disease associations.

Alopecia treatments improve life quality but side effects can lessen this benefit; better use of quality of life measures is needed.

Androgenetic alopecia significantly affects quality of life, especially for women, who are more willing to pay for treatment.

Hormonal therapies can improve skin issues by adjusting hormone levels, with future advancements promising better results.

Microneedles could revolutionize pediatric medicine by offering painless drug delivery, but more development is needed.

TH07 treatment is promising for hair growth, with higher satisfaction in males.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

MicroRNA-21 could help diagnose and treat skin fibrosis.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Both dutasteride and finasteride improve urinary symptoms, but dutasteride may be better at reducing the risk of prostate surgery and sudden inability to urinate.

The electronic version of the Dermatology Life Quality Index is as effective as the paper version, with most patients preferring it.

Finasteride doesn't harm quality of life.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Cataract surgery in Europe varies in frequency and cost between countries.

The document concludes that PK/PD modeling is important for determining the safe and effective dosages of drugs.

The conclusion is that combining social and cultural factors with pharmaceutical research could improve our understanding of how drugs work.

Using existing drugs for new treatments is cost-effective and safer.

Drug repurposing can speed up and reduce costs in drug discovery, especially for cancer treatment.

Qianliekang and liuweidihuangwan are cheaper for BPH treatment than finasteride and tamsulosin.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Drug repurposing can be cost-effective but needs more testing for safety and effectiveness.

Adopting the Mark Cuban Cost Plus Drug Company pricing model could save Medicare about $1.29 billion on urological drugs.

Using Mark Cuban Cost Plus Drug Company can save money on men's health medications compared to Medicare.